We are proud to partner with the iHeart #MobilizeRecovery Bus Tour. This initiative is connecting communities across the U.S. and raising awareness about addiction and recovery. By working together, we can help educate communities on how to be prepared to act in the event of an overdose. Learn more: TakingControlOverIt.com
Amneal Pharmaceuticals
Pharmaceutical Manufacturing
Bridgewater, New Jersey 183,864 followers
We make healthy possible.
About us
Amneal (NASDAQ: AMRX) is rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Our family delivers for yours through a robust U.S. generics business, a growing branded business and deepening portfolios in injectables, biosimilars and select international markets. We’ve bolstered our world-class scientific rigor, production capabilities and commercial infrastructure. And we invest substantially in our people through leadership development and employee well-being programs – all so we can deliver even more value. We are Amneal and We make healthy possible. Content is for informational purposes only and 3rd party content does not reflect Amneal’s opinions. Amneal has the right to remove comments that violate another’s copyright or intellectual property, mention an Amneal product, use profanity or are defamatory, promote and solicit for third-party sites, initiatives, or products, or are factually inaccurate or misleading or spam. Amneal recommends that you consult with your healthcare provider regarding personal health matters. To report a product complaint or adverse event related to an Amneal product, contact Drug Safety at 877-835-5472, option 3 or drugsafety@amneal.com. If you are currently experiencing a life-threatening event, please immediately contact 911.
- Website
-
http://www.amneal.com
External link for Amneal Pharmaceuticals
- Industry
- Pharmaceutical Manufacturing
- Company size
- 5,001-10,000 employees
- Headquarters
- Bridgewater, New Jersey
- Type
- Public Company
- Founded
- 2002
Locations
-
Primary
400 Crossing Boulevard
Bridgewater, New Jersey 08807, US
Employees at Amneal Pharmaceuticals
Updates
-
Let's continue to raise awareness about the opioid crisis and how we can be prepared to act in the event of an overdose.
Overdoses are the leading injury-related cause of death in the U.S., and most overdose deaths involve an opioid. But recognizing an opioid overdose can be difficult. If you aren’t sure, it is best to treat the situation like an overdose — you could save a life. Learn more about preventing opioid overdose at the Centers for Disease Control and Prevention : https://bit.ly/3BqUXEh
-
A huge thank you to everyone who visited Amneal at our booth during the Movement Disorder Society conference last weekend in Philadelphia, PA! Your enthusiasm for CREXONT® and ONGENTYS® while attending our educational events underscores the vital role continuous learning and innovation play in healthcare. Together, we’re shaping the future of patient care.
-
Thank you to U.S. Secretary of Commerce Gina Raimondo and Minister of Commerce and Industry of India Piyush Goyal for hosting this week’s US-India Forum Meeting. Represented by our Co-Founder and Co-CEO Chirag Patel as Chair of the Healthcare and Pharmaceutical Working Group, we are proud to be part of the Forum and doing our part to address today’s critical health challenges for patients in the U.S. and India.
Yesterday, the United States hosted the second in-person meeting of the U.S.-India Forum co-chaired by U.S. Secretary of Commerce Gina Raimondo and Minister of Commerce and Industry of India Piyush Goyal. The U.S.-India CEO Forum is a platform that convenes leaders of the U.S. and Indian business communities to develop and provide joint recommendations to strengthen bilateral commercial ties and expand trade and investment between India and the United States. https://lnkd.in/e42tFKMv
-
Earlier today we announced a strategic collaboration that positions Amneal and Metsera to deliver weight loss and metabolic disease medicines at scale. In this short video, Amneal Co-CEOs Chirag and Chintu Patel, Clive Meanwell, Executive Chairman of Metsera, and Whit Bernard, CEO of Metsera, discuss the significance of the announcement. Please reference our press release for more information, including forward-looking statements: https://lnkd.in/eGWBWcZ8
-
Today we announced a strategic collaboration with Metsera, a clinical-stage biopharmaceutical company, to accelerate the next-generation medicines for obesity and metabolic diseases. We are excited to leverage our deep expertise in product development, high-quality and cost-effective manufacturing, and our ability to rapidly scale-up to help increase access to this important new category of medicines for patients around the world. Read our press release here: https://lnkd.in/eGWBWcZ8 #Obesity #MetabolicDisease #AffordableMedicines #EssentialMedicines #PatientAccess #GLP-1
-
In 2023, #generics & #biosimilars saved America’s patients and the U.S. healthcare system $445 billion. Learn more: https://lnkd.in/gzbEVUa7
-
We’re growing in key areas of medicine. Learn more: Amneal.com *Amneal has three reportable business segments: 1) Generics (includes retail, injectables, biosimilars & international revenue), 2) Specialty and 3) AvKARE (includes distribution, government label and institutional revenue).
Similar pages
Browse jobs
Stock
AMRX
NASDAQ
20 minutes delay
$8.57
0.11 (1.3%)
- Open
- 8.5
- Low
- 8.46
- High
- 8.605
Data from Refinitiv
See more info on